Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Novel LTB4 receptor antagonist described

Feb. 20, 1997

Antiacne treatment available in the U.K.

Feb. 19, 1997

Dermik launches new acne medication

Feb. 14, 1997

Gliatech's ADCON-L nears FDA approval

Feb. 14, 1997

Penederm receives U.K. marketing approval for topical acne treatment

Feb. 13, 1997

Development partner sought for new wound dressing

Feb. 12, 1997

Teva presents potential antipsoriatic agents

Feb. 12, 1997

Tretinoin gel cleared for marketing by FDA

Feb. 11, 1997

Tsumura describes agents for dermatitis

Feb. 7, 1997

Hyal's Solarase submitted for approval

Feb. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.